Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticles
Cheng Zou(Air Force Medical University), Meng Li(Air Force Medical University), Jiying Ma(Air Force Medical University), Wangqian Zhang(Air Force Medical University), Anan Yin(Xijing Hospital), Lei He(Harvard University), Xiaolin Liu(Qingdao National Laboratory for Marine Science and Technology), Wei Liu(The University of Texas MD Anderson Cancer Center), Weizhong Wang(Xijing Hospital), Yingqi Zhang(Tongji University), Yalong He(Xijing Hospital), Yuxin Wu(Air Force Medical University), Shuning Wang(Air Force Medical University), Xiao Liu(Central South University), Lin Wei(Xijing Hospital), Jintao Gu(Air Force Medical University), Maorong Zhu(Air Force Medical University), Kuo Zhang(Hebei Medical University), Zhengcong Cao(Air Force Medical University)
Cited by 15
Related Papers
Iridium single-atom catalyst on nitrogen-doped carbon for formic acid oxidation synthesized using a general host–guest strategy
|Nature Chemistry|2020|701
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
|Cancer Discovery|2012|622
Biomedical polymers: synthesis, properties, and applications
|Science China Chemistry|2022|187
Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma
|ACS Nano|2023|181
N-Coordinated Dual-Metal Single-Site Catalyst for Low-Temperature CO Oxidation
|ACS Catalysis|2020|174